Placental transfer of and infantile exposure to perchlorate

Tao Zhang1, Yufang Ma2, Dou Wang3

  • 1School of Environmental Science and Engineering, Sun Yat-Sen University, Guangzhou 510275, China; Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology (Sun Yat-Sen University), Guangzhou 510275, China; College of Environmental Sciences and Engineering, Nankai University, Tianjin 300071, China.

Chemosphere
|October 4, 2015
PubMed

Insights

Perchlorate is widespread in Chinese infants and fetuses, with levels significantly higher than in the U.S. Many infants exceed safe perchlorate intake levels, primarily through breast milk or formula.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pediatrics

Background:

  • Perchlorate poses a risk to vulnerable fetuses and infants.
  • Understanding perchlorate exposure pathways is crucial for public health.

Purpose of the Study:

  • To assess fetal and infantile exposure to perchlorate in Nanchang and Tianjin, China.
  • To identify primary exposure sources and compare levels to U.S. data.

Main Methods:

  • Collected breast milk, infant formula, infant urine, maternal blood, and cord blood samples.
  • Measured perchlorate concentrations using analytical methods.
  • Estimated daily perchlorate intake and compared to the U.S. EPA's reference dose (RfD).

Main Results:

  • Perchlorate detected in 82%-100% of samples, with levels 10x higher than U.S. reports.
  • Infant urine, breast milk, and cord blood perchlorate levels were significantly elevated.
  • 40% of infants exceeded the U.S. EPA's RfD; 70% of breastfed infants exceeded RfD via breast milk.
  • Placental transfer of perchlorate confirmed; breast milk is a major source for infants.

Conclusions:

  • Chinese fetuses and infants face significant perchlorate exposure.
  • Current exposure levels, particularly via breast milk, exceed safety guidelines.
  • Further research and potential interventions are warranted to mitigate risks.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.7K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.5K
Drug Excretion: Pulmonary and Glandular Routes01:22

Drug Excretion: Pulmonary and Glandular Routes

Gaseous substances like general anesthetics are absorbed and excreted through the lungs via simple diffusion. This process depends on factors such as pulmonary blood flow, respiration rate, and the substance's solubility. Gaseous anesthetics like nitrous oxide with low blood solubility are excreted rapidly, while compounds like alcohol, with high blood and tissue solubility, are excreted slowly.
Drugs can also be excreted in breast milk, which is crucial for breastfeeding infants. The...
903
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.8K